Healthcare

By

Jim Cramer

 | Apr 26, 2016 | 7:20 AM EDT

Everything about the CEO's move to Valeant stinks.

By

Bret Jensen

 | Apr 25, 2016 | 12:00 PM EDT

This stock is undervalued and has good products in the pipeline.

By

Carleton English

 | Apr 25, 2016 | 11:25 AM EDT

The synthetic biology firm recently came under attack by an unknown short-seller, raising questions about market manipulation.

By

James Passeri

 | Apr 25, 2016 | 10:40 AM EDT

Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat. 

By

James Passeri

 | Apr 22, 2016 | 12:50 PM EDT

Wall Street is confident that Valeant can turn around its steep share price decline with the right successor as CEO.

By

Mark Newton

 | Apr 22, 2016 | 5:30 AM EDT
By

Jeremy LaKosh

 | Apr 20, 2016 | 10:00 AM EDT

UNH investors should have the same confidence as analysts.

By

David Katz

 | Apr 20, 2016 | 7:00 AM EDT

Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.

By

Bruce Kamich

 | Apr 19, 2016 | 3:00 PM EDT

Look for JNJ to trade higher, but a close below $107 will turn the picture to bearish from bullish. 

By

Chris Laudani

 | Apr 19, 2016 | 1:00 PM EDT

Stock is up some 14% YTD, but good news might already be priced in.

1 More Questions for Apple's Tim Cook 2. More Market Thoughts 3. The latest political odd...

Coming up!

National Oilwell Varco (NOV) is a big energy equipment maker in the cyclical doldrums. Its...
Among the famed Danaher (DHR) wannabes in mid-cap industrial land, Colfax (CFX) continues ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.